202 related articles for article (PubMed ID: 10224501)
21. Thrombospondin-1 and transforming growth factor beta-1 upregulate plasminogen activator inhibitor type 1 in pancreatic cancer.
Albo D; Berger DH; Vogel J; Tuszynski GP
J Gastrointest Surg; 1999; 3(4):411-7. PubMed ID: 10482694
[TBL] [Abstract][Full Text] [Related]
22. Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasiveness.
Bryan L; Paugh BS; Kapitonov D; Wilczynska KM; Alvarez SM; Singh SK; Milstien S; Spiegel S; Kordula T
Mol Cancer Res; 2008 Sep; 6(9):1469-77. PubMed ID: 18819934
[TBL] [Abstract][Full Text] [Related]
23. Oxygen modulates the release of urokinase and plasminogen activator inhibitor-1 by retinal pigment epithelial cells.
Erichsen JT; Jarvis-Evans J; Khaliq A; Boulton M
Int J Biochem Cell Biol; 2001 Mar; 33(3):237-47. PubMed ID: 11311855
[TBL] [Abstract][Full Text] [Related]
24. Transforming growth factor-beta1 produced by ovarian cancer cell line HRA stimulates attachment and invasion through an up-regulation of plasminogen activator inhibitor type-1 in human peritoneal mesothelial cells.
Hirashima Y; Kobayashi H; Suzuki M; Tanaka Y; Kanayama N; Terao T
J Biol Chem; 2003 Jul; 278(29):26793-802. PubMed ID: 12743121
[TBL] [Abstract][Full Text] [Related]
25. Urokinase receptor in human malignant mesothelioma cells: role in tumor cell mitogenesis and proteolysis.
Shetty S; Kumar A; Johnson A; Pueblitz S; Idell S
Am J Physiol; 1995 Jun; 268(6 Pt 1):L972-82. PubMed ID: 7611439
[TBL] [Abstract][Full Text] [Related]
26. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
[TBL] [Abstract][Full Text] [Related]
27. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
[TBL] [Abstract][Full Text] [Related]
28. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.
Allan EH; Martin TJ
J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231
[TBL] [Abstract][Full Text] [Related]
29. Thrombospondin-1 and transforming growth factor-beta l promote breast tumor cell invasion through up-regulation of the plasminogen/plasmin system.
Albo D; Berger DH; Wang TN; Hu X; Rothman V; Tuszynski GP
Surgery; 1997 Aug; 122(2):493-9; discussion 499-500. PubMed ID: 9288157
[TBL] [Abstract][Full Text] [Related]
30. Induction of the plasminogen activator system by mechanical stimulation of human bronchial epithelial cells.
Chu EK; Cheng J; Foley JS; Mecham BH; Owen CA; Haley KJ; Mariani TJ; Kohane IS; Tschumperlin DJ; Drazen JM
Am J Respir Cell Mol Biol; 2006 Dec; 35(6):628-38. PubMed ID: 16794260
[TBL] [Abstract][Full Text] [Related]
31. Thrombin increases expression of urokinase receptor by activation of the thrombin receptor.
Yang Z; Cohen RL; Lui GM; Lawrence DA; Shuman MA
Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2254-61. PubMed ID: 7558719
[TBL] [Abstract][Full Text] [Related]
32. Interferons and retinoids enhance and dexamethasone suppresses urokinase-mediated plasminogen activation in promyelocytic leukemia cells.
Mustjoki S; Tapiovaara H; Sirén V; Vaheri A
Leukemia; 1998 Feb; 12(2):164-74. PubMed ID: 9519778
[TBL] [Abstract][Full Text] [Related]
33. Urokinase-mediated posttranscriptional regulation of urokinase-receptor expression in non small cell lung carcinoma.
Montuori N; Mattiello A; Mancini A; Taglialatela P; Caputi M; Rossi G; Ragno P
Int J Cancer; 2003 Jun; 105(3):353-60. PubMed ID: 12704669
[TBL] [Abstract][Full Text] [Related]
34. Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle.
Nordengren J; Pilka R; Noskova V; Ehinger A; Domanski H; Andersson C; Høyer-Hansen G; Hansson SR; Casslén B
Mol Hum Reprod; 2004 Sep; 10(9):655-63. PubMed ID: 15243126
[TBL] [Abstract][Full Text] [Related]
35. Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells.
Arnoletti JP; Albo D; Granick MS; Solomon MP; Castiglioni A; Rothman VL; Tuszynski GP
Cancer; 1995 Sep; 76(6):998-1005. PubMed ID: 8625226
[TBL] [Abstract][Full Text] [Related]
36. Effect of transforming growth factor-beta on the plasminogen activator system in cultured first trimester human cytotrophoblasts.
Graham CH
Placenta; 1997; 18(2-3):137-43. PubMed ID: 9089774
[TBL] [Abstract][Full Text] [Related]
37. Suppression of urokinase receptor expression by thalidomide is associated with inhibition of nuclear factor kappaB activation and subsequently suppressed ovarian cancer dissemination.
Kobayashi H; Yagyu T; Kondo T; Kurita N; Inagaki K; Haruta S; Kawaguchi R; Kitanaka T; Sakamoto Y; Yamada Y; Kanayama N; Terao T
Cancer Res; 2005 Nov; 65(22):10464-71. PubMed ID: 16288038
[TBL] [Abstract][Full Text] [Related]
38. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.
Guda K; Claffey KP; Dong M; Nambiar PR; Rosenberg DW
Mol Carcinog; 2003 May; 37(1):51-9. PubMed ID: 12720300
[TBL] [Abstract][Full Text] [Related]
39. Effect of TGF-beta on interferon-gamma-induced HLA-DR expression in human retinal pigment epithelial cells.
Gabrielian K; Osusky R; Sippy BD; Ryan SJ; Hinton DR
Invest Ophthalmol Vis Sci; 1994 Dec; 35(13):4253-9. PubMed ID: 8002245
[TBL] [Abstract][Full Text] [Related]
40. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.
Iwamoto J; Mizokami Y; Takahashi K; Nakajima K; Ohtsubo T; Miura S; Narasaka T; Takeyama H; Omata T; Shimokobe K; Ito M; Takehara H; Matsuoka T
Scand J Gastroenterol; 2005 Jul; 40(7):783-93. PubMed ID: 16109653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]